Takeshi Sakurai | Neuroanatomy | Best Researcher Award

Prof. Dr. Takeshi Sakurai | Neuroanatomy | Best Researcher Award

Prof. Dr. Takeshi Sakurai, University of Tsukuba, Japan.

Takeshi Sakurai, M.D., Ph.D., is a distinguished academic whose career spans across key positions in neuroscience, pharmacology, and integrative sleep medicine. After earning his M.D. and Ph.D. from the University of Tsukuba, he embarked on a journey of groundbreaking research, primarily focusing on neurotransmission and sleep regulation. Sakurai’s postdoctoral work in prestigious institutions, coupled with his leadership of major projects like the Yanagisawa Orphan Receptor Project, established him as a leader in molecular neuroscience. Over the years, he has earned recognition through accolades and significant academic positions, including his current role as Professor and Vice Director at the University of Tsukuba’s International Institute for Integrative Sleep Medicine. His research continues to shape the understanding of sleep and brain function, while his influence extends to mentoring the next generation of scientists.

Profile

Google Scholar

Early Academic Pursuits 📚


Takeshi Sakurai’s academic journey began with his medical studies at the University of Tsukuba, where he earned his M.D. in 1989. During his early years at the university, he developed a keen interest in the molecular mechanisms of biological systems. This curiosity led him to pursue a Ph.D. in medicine, which he completed in 1993. His doctoral research focused on the cloning of a cDNA encoding a non-isopetide-selective subtype of the endothelin receptor, a project that was published in Nature in 1990, marking the beginning of his significant contributions to molecular pharmacology.

Professional Endeavors 👨‍⚕️


Following his Ph.D., Sakurai embarked on a promising career in academic research, starting as a postdoctoral fellow at the Institute of Basic Medical Sciences in 1993. His career rapidly advanced as he took on various roles, including Assistant Professor at the same institute. During his tenure, he also worked as a postdoctoral fellow at the prestigious Howard Hughes Medical Institute at the University of Texas Southwestern Medical Center in Dallas from 1995 to 1996. These experiences broadened his expertise in pharmacology and molecular neuroscience, laying the foundation for his future academic leadership roles. By 1999, he became an Associate Professor at the University of Tsukuba and contributed significantly to the university’s research landscape.

Contributions and Research Focus 🧬


Sakurai’s research is primarily centered around molecular neuroscience, pharmacology, and integrative physiology. His work has been pivotal in advancing the understanding of biological systems and their regulation at the molecular level. Notably, his leadership of the Yanagisawa Orphan Receptor Project under the Exploratory Research for Advanced Technology (ERATO) of the Japan Science and Technology Corporation highlights his role in pioneering research on orphan receptors. His continued focus on the mechanisms of neurotransmission and their involvement in sleep regulation has earned him a place as a leading researcher in the field of integrative sleep medicine.

Accolades and Recognition 🏆


Throughout his career, Sakurai has earned widespread recognition for his contributions to medicine and neuroscience. His groundbreaking work on neurotransmitter systems and sleep regulation has led to his appointment as a Professor and Vice Director at the University of Tsukuba’s International Institute for Integrative Sleep Medicine. His research has not only shaped the scientific community’s understanding of brain function but also garnered him numerous accolades, further cementing his reputation as a thought leader in the field.

Impact and Influence 🌍


Sakurai’s impact extends far beyond his own research. As a professor, he has mentored countless students and researchers who have gone on to make their own significant contributions in the fields of neuroscience and pharmacology. His interdisciplinary approach to sleep medicine has influenced research on neurodegenerative diseases, mental health, and drug development. The work he has pioneered in molecular neuroscience has also paved the way for advances in treatment approaches for disorders related to sleep and neurotransmission, offering hope for improved therapeutic interventions.

Legacy and Future Contributions 🔬


Looking ahead, Sakurai’s legacy in neuroscience and integrative sleep medicine is poised to continue influencing both academic research and clinical practice. His innovative research on sleep regulation and the molecular mechanisms underpinning brain function will undoubtedly remain foundational in the future of both basic and applied medical sciences. As he continues his work at the University of Tsukuba, Sakurai’s future contributions will likely expand our understanding of the brain’s intricate systems and their broader implications for human health. His career exemplifies a dedication to advancing science, and his ongoing research promises to address critical challenges in medicine and health.

Academic Leadership and Mentorship 🎓


In addition to his personal research achievements, Sakurai’s role in academic leadership cannot be understated. As a professor at the University of Tsukuba, he has played a pivotal role in shaping the institution’s research direction and academic programs, particularly within the fields of integrative physiology and sleep medicine. His influence extends through the mentorship of students, guiding the next generation of researchers who will continue to build on his work. Sakurai’s commitment to education and his support for innovative research initiatives are key to his lasting impact on the academic and medical communities.

Publication

  • Orexins and orexin receptors: a family of hypothalamic neuropeptides and G protein-coupled receptors that regulate feeding behavior
    Authors: T Sakurai, A Amemiya, M Ishii, I Matsuzaki, RM Chemelli, H Tanaka, …
    Year: 1998

 

  • Cloning of a cDNA encoding a non-isopeptide-selective subtype of the endothelin receptor
    Authors: T Sakurai, M Yanagisawa, Y Takuwat, H Miyazakit, S Kimura, K Goto, …
    Year: 1990

 

  • Genetic ablation of orexin neurons in mice results in narcolepsy, hypophagia, and obesity
    Authors: J Hara, CT Beuckmann, T Nambu, JT Willie, RM Chemelli, CM Sinton, …
    Year: 2001

 

  • Autism genome-wide copy number variation reveals ubiquitin and neuronal genes
    Authors: JT Glessner, K Wang, G Cai, O Korvatska, CE Kim, S Wood, H Zhang, …
    Year: 2009

 

  • The neural circuit of orexin (hypocretin): maintaining sleep and wakefulness
    Author: T Sakurai
    Year: 2007

 

  • Distribution of orexin neurons in the adult rat brain
    Authors: T Nambu, T Sakurai, K Mizukami, Y Hosoya, M Yanagisawa, K Goto
    Year: 1999

 

  • Orexins, orexigenic hypothalamic peptides, interact with autonomic, neuroendocrine and neuroregulatory systems
    Authors: Y Date, Y Ueta, H Yamashita, H Yamaguchi, S Matsukura, K Kangawa, …
    Year: 1999

 

  • Hypothalamic orexin neurons regulate arousal according to energy balance in mice
    Authors: A Yamanaka, CT Beuckmann, JT Willie, J Hara, N Tsujino, M Mieda, …
    Year: 2003

 

  • Plastic stress-strain matrix and its application for the solution of elastic-plastic problems by the finite element method
    Authors: Y Yamada, N Yoshimura, T Sakurai
    Year: 1968

 

  • Chemically defined projections linking the mediobasal hypothalamus and the lateral hypothalamic area
    Authors: CF Elias, CB Saper, E Maratos‐Flier, NA Tritos, C Lee, J Kelly, JB Tatro, …
    Year: 1998

 

Conclusion


Takeshi Sakurai’s work has profoundly impacted the fields of neuroscience, pharmacology, and sleep medicine. His contributions have not only advanced scientific understanding but have also paved the way for practical applications in medical therapies. Through his leadership and mentorship, Sakurai’s legacy is set to endure, with his future research promising further advancements in understanding the complexities of the brain and its regulation. His dedication to advancing both science and education ensures that his influence will continue to resonate in academic and clinical circles for years to come.

 

Nawal Al-Subaie | Clinical Neuroscience | Best Researcher Award

Assist Prof Dr. Nawal Al-Subaie | Clinical Neuroscience | Best Researcher Award

Assist Prof Dr. Nawal Al-Subaie,  Princess Noura University, Saudi Arabia

Nawal Al Subaie is a dedicated Clinical Pharmacist with extensive experience in clinical and academic roles at esteemed institutions, including Prince Sultan Military Medical City (PSMMC) and Princess Noura University (PNU). She holds a PhD in Clinical Pharmacy from DMU, UK, and a Master’s in International Practice and Policy from UCL, London. With a career spanning leadership, clinical care, and education, she has made significant contributions to pharmacy practice, quality control, and chronic disease management. Her commitment to continuous learning is reflected in numerous specialized courses and symposiums, along with frequent contributions to global conferences.

 

profile

scholor

🎓 Educational Background

PhD in Clinical Pharmacy,DMU Leicester, United Kingdom.MSc in Clinical Pharmacy (International Practice and Policy)
,UCL School of Pharmacy, London, United Kingdom.Bachelor’s Degree in Hospital Pharmacy,King Saud University, Riyadh, Saudi Arabia.

💼 Working Experience

Deputy in Charge of Pharmacy Division.Family and Community Medicine.Lead Pharmacist. Wazarat Health Centre (WHC).Clinical Pharmacist,Chronic Disease Clinic, WHC.Clinical Instructor / Trainer,Continuous education for pharmacy students at King Saud University, Princess Noura University, Northern Border University.Quality Control Representative Pharmacy, WHC.Part-time Lecturer,Clinical Ocular Pharmacology, King Saud University.JCI Accreditation Awardee,Primary Care Team.In-Charge of Clinical Pharmacist Ambulatory Care Clinics, PSMMC, 2020–2022.Assistant Professor,Princess Noura University (PNU), May 2022 – Present.

🏫 Training Courses / Symposiums

2015 – 2019: PhD Student (Diabetes and Exercise)Pharmacy School, DMU, UK.2014: TOT Course Leicester, UK.2016: Phlebotomy Course Nottingham, UK.2016: First Aid CourseLeicester, UK.2022: ASHP Diabetes Management Certificate Course January – December 2022.

🌍 Conferences Attended & Contributions

2024: Attended the 4th Saudi Society of Clinical Pharmacist Annual International Conference (September).2024: Presented Poster at Dubai International Pharmaceuticals and Technologies Conference.2023: Oral Presentation at Neurology Conference, Dubai (March).2023: Judge, Pharmacy Research Day, PNU Research Center (May).2022: Attended First Saudi Society of Clinical Pharmacist Annual International Conference (September)(and many more from 2000 to 2024)

🤲 Voluntary Work

University orientation for new students, DMU. Diabetes Awareness Day, in collaboration with Diabetes UK. Trained students at DMU on ELISA and Randox machine for blood sample analysis. Assisted pharmacy students with projects and dissertations, DMU

🏅 Professional Memberships

Saudi Commission for Health Specialties (ID: 09-R-P-0295492)

📚 Publications

  1. Statins Use in Alzheimer Disease: Bane or Boon from Frantic Search and Narrative Review
    Authors: N. Alsubaie, H.M. Al-Kuraishy, A.I. Al-Gareeb, B. Alharbi, M. De Waard, …
    Year: 2022

 

  1. Discussing Pathologic Mechanisms of Diabetic Retinopathy & Therapeutic Potentials of Curcumin and β-glucogallin in the Management of Diabetic Retinopathy
    Authors: M. Rohilla, S. Bansal, A. Garg, S. Dhiman, S. Dhankhar, M. Saini, S. Chauhan, …
    Year: 2023

 

  1. The Potential Therapeutic Effect of Metformin in Type 2 Diabetic Patients with Severe COVID-19
    Authors: H.M. Al-Kuraishy, A.I. Al-Gareeb, A.A. El Kholy, E. El-Khateeb, A. Alexiou, …
    Year: 2023

 

  1. The Effects of a Combined Exercise Programme Aerobic and Resistance on Blood Glucose, Incretin, Metabolic and Inflammatory Mediators that Could Control the Diabetes and Improve …
    Author: N. Alsubaie
    Year: 2019

 

  1. Corrigendum to “Discussing Pathologic Mechanisms of Diabetic Retinopathy & Therapeutic Potentials of Curcumin and β-glucogallin in the Management of Diabetic Retinopathy”
    Authors: M. Rohilla, S. Bansal, A. Garg, S. Dhiman, S. Dhankhar, M. Saini, S. Chauhan, …
    Year: 2024

 

  1. Impact of Clinical Pharmacist Diabetes Clinic on the Improvement of Health Outcomes in Type 2 Diabetes Subjects
    Authors: N. AlSubaie, M. Alsallal, S. AlTwaijri, A. AlOtaibi, B. AlHarbi, M. AlEissa, …
    Year: 2022

 

  1. The Effects of a Combined Aerobic and Resistance Exercise Programme on Insulin Resistance Among Prediabetes Subjects
    Authors: B. Alharbi, N. Alsubaie, T.S. Sahota, M.J. Taylor
    Year: 2019

 

  1. The Effects of a Combined Exercise Programme (Aerobic and Resistance) on Blood Glucose and Incretin Hormone That Could Control the Diabetes in Type 2 Diabetes
    Authors: N. Alsubaie, B. Alharbi, T.S. Sahota, M.J. Taylor
    Year: 2019

 

  1. The Effects of a Combined Exercise Programme (Aerobic and Resistance) on Blood Glucose, and Incretin Hormone That Could Control the Diabetes in Type 2 Diabetes
    Authors: B.M. Alharbi, N.S. Alsubaie, T.S. Sahota, M.J. Taylor
    Year: 2019

 

  1. The Impact of Moderate Combination Exercise on HbA1c, IL-6, and TNF in Type 2 Diabetic and Non-diabetic Subjects: An Interventional Non-randomized Clinical Trial
    Authors: B. Alharbi, N. Alsubaie, T.S. Sahota, M.J. Taylor
    Year: 2019

 

 Conclusion

Dr. Al Subaie’s career showcases a deep commitment to enhancing patient care, advancing pharmaceutical education, and contributing to international health discussions. Her background in both hands-on clinical care and academic research equips her with a well-rounded perspective, making her a valuable asset in clinical and educational settings alike. She continues to make strides in diabetes management, chronic disease care, and pharmacy education, with her work recognized through multiple presentations, awards, and professional memberships.